Life Science Company News

Reset
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Kazia Therapeutics Announces $2 Million Registered Direct Offering

Read more ››
By: PR Newswire Association LLC. - 01 Dec 2023
Related companies:  Kazia Therapeutics Limited

The highest incidence of OHCA is at home, with 3 cases of young OHCA occurring at home every week.

Read more ››
By: PR Newswire Association LLC. - 01 Dec 2023

Jazz Pharmaceuticals to Present Long-Term and Real-World Data Emphasizing Commitment to Treatment-Resistant Epilepsy at the 2023 American Epilepsy Society Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 01 Dec 2023
Related companies:  Jazz Pharmaceuticals plc

This Week in Health News: 10 Stories You Need to See

Read more ››
By: PR Newswire Association LLC. - 01 Dec 2023
Related companies:  PR Newswire

Nanoscope Therapeutics Announces Presentation at the FLORetina 2023 Congress

Read more ››
By: PR Newswire Association LLC. - 01 Dec 2023
Related companies:  Nanoscope Therapeutics, Inc

Tampa General Hospital Completes Acquisition of Bravera Health and Introduces "TGH North"

Read more ››
By: PR Newswire Association LLC. - 01 Dec 2023

Neurocrine Biosciences to Host Analyst Day on December 5, 2023

Read more ››
By: PR Newswire Association LLC. - 01 Dec 2023
Related companies:  Neurocrine Biosciences, Inc.

UCB presents new data advancing patient-focused scientific leadership at American Epilepsy Society Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 01 Dec 2023
Related companies:  UCB INC. (US) | UCB

"HyBryte™ Use in Early-Stage Cutaneous T-Cell Lymphoma" Published in Frontiers in Drug Discovery

Read more ››
By: PR Newswire Association LLC. - 01 Dec 2023
Related companies:  Soligenix, Inc.

UM School of Medicine Dean Leads International Trial for Novel Sickle Cell Treatment

Read more ››
By: PR Newswire Association LLC. - 01 Dec 2023

Nutjobs Inc. Welcomes Jeff Anderson as New CEO

Read more ››
By: PR Newswire Association LLC. - 01 Dec 2023

280Bio doses first patient in Phase I clinical trial of TEB-17231, an oral pan-RAS inhibitor in patients with advanced cancers harboring mutations in KRAS, HRAS, or NRAS

Read more ››
By: PR Newswire Association LLC. - 01 Dec 2023

Potrero Medical Announces Restructuring and Continued Operations

Read more ››
By: PR Newswire Association LLC. - 01 Dec 2023
Related companies:  Potrero Medical | Potrero Hill Therapeutics

Intensity Therapeutics Selected for Spotlight Oral Presentation at the 2023 San Antonio Breast Cancer Symposium

Read more ››
By: PR Newswire Association LLC. - 01 Dec 2023
Related companies:  Intensity Therapeutics, Inc.

NeuroBo to Participate in Investor Conferences in December

Read more ››
By: PR Newswire Association LLC. - 01 Dec 2023
Related companies:  NeuroBo Pharmaceuticals, Inc.

BPI Sports and Hi-Tech Pharmaceuticals Complete First Prepackaged Chapter 5 and Promptly Emerge Positioned for Long-Term Growth

Read more ››
By: PR Newswire Association LLC. - 01 Dec 2023

Introducing Mundus Mini HD by EQUASHIELD: Redefining the Safe Handling of Hazardous Drugs

Read more ››
By: PR Newswire Association LLC. - 01 Dec 2023

Martha Rosenberg's Explosive Exposé Reveals Shocking Truths about Big Pharma and Big Food: NewsBlaze

Read more ››
By: PR Newswire Association LLC. - 01 Dec 2023

HOUSING WORKS COMMEMORATES WORLD AIDS DAY & ANNOUNCES OPENING OF NEW WESTSIDE COMMUNITY HEALTH CENTER

Read more ››
By: PR Newswire Association LLC. - 01 Dec 2023

NEURELIS ANNOUNCES PRESENTATIONS AT THE AMERICAN EPILEPSY SOCIETY ANNUAL MEETING

Read more ››
By: PR Newswire Association LLC. - 01 Dec 2023
Related companies:  Neurelis, Inc.
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »